Statin treatment may bring down the chance of later dementia by more than 50%, a domestic Finnish report has ascertained.

“Perturbations in cholesterol metabolic process have previously been connected to dementia evolution,” Dr. Alina Solomon wrote in a poster introduced at the International Conference on Alzheimer’s Disease. All the same, Dr. Solomon, of the University of Kuopio, Finland, observed that not all studies have reasoned that statins bestow a preventive effect against dementia onset.

Doctor. Solomon and her fellows analyzed this question applying information elicited from the national FINRISK report, an extensive, population-based review of cardiovascular risk elements among Finnish citizens. The survey started in 1972 and is conducted every five years. MD. Solomon’s substudy of FINRISK included information about 17,257 citizens who were included in the 1997 and 2002 cohorts, and who were at least 60 years old in 1995, when statins became accessible in Finland.

By the study’s conclusion at 2007, 1,551 of the subjects had acquired dementia and 15,706 hadn’t. Just 18% of those who developed dementia had gotten at least 1 year of statin therapy, while 37% of those who were dementia-free had taken a statin – a substantial deviation.

No meaningful affiliations were ascertained between dementia and the consumption of other cholesterol-lowering medicines, doctor. Solomon stated, indicating that “the effect of statins in dementia is partially unaffiliated of their cholesterol-lowering effect.”

Subjects who acquired dementia likewise had significantly greater baseline total cholesterol and baseline systolic and diastolic blood pressure. But a variable regression framework that controlled for age, gender, education, cholesterol, weight, and blood pressure still ascertained that statins bestowed a 57% risk decrease for dementia across the run of the study.

The determination doesn’t establish that statins prevent dementia. But it does indicate that more reports should research the theme, centering on statin types, doses, and length of treatment, doctor. Solomon stated at the gathering, which was sponsored by the Alzheimer’s Association.

Neither she nor her coinvestigators announced any possible conflict of interest in relation to the report.

Presently, there’s no cure for Alzheimer’s disease, in spite of the number of folks stricken with this disease. Various treatments have been useful in retarding and assuaging many of the symptoms, especially mental confusion and anxiousness, but nothing has been proven to stop the advancement of the illness itself. While treatment and care for Alzheimer’s disease has been advancing, scientists are nonetheless at a loss for where to look to discover an Alzheimer’s remedy.

Research Towards a Remedy

Much research has been done into nutritionary and complementary medicine as a potential step towards an Alzheimer’s cure. The antioxidant Vitamins C and E, as well as the omega-3 fatty acid existing in fish oils, have been proven to improve cognitive functions and to slow down the progress of the disease. Additionally, research is being done involving the utility of the herbaceous plant gingko biloba in caring for, preventing, or healing Alzheimer’s.

Research is likewise being carried on toward producing an Alzheimer’s vaccine. Opposed to other vaccines, which are conferred before the contraction of a disease, the Alzheimer’s disease vaccine would be given to folks who have already been diagnosed with Alzheimer’s disease. Its purpose would be to condition the body to assail the chemical compounds that contribute to brain troubles. New tests of this vaccine were halted, however, when a lot of the participants experienced serious side effects, including swelling of the brain.

Additional auspicious fields of research towards an Alzheimer’s remedy lies with the cholesterol reducing drugs known as Statins. They’ve been proven in many empirical analyses to have favorable results upon cognitive functioning, but this hasn’t thus far been verified by observational research. Likewise nonsteroidal anti-inflammatory drugs,, such as acetaminophen and aspirin, have been evidenced to have some effect only more research is necessitated.

One treatment that was believed to allow for relief has, regrettably, lately been controverted. The Women’s Health Initiative, among the greatest longitudinal wellness reports ever executed, indicated that Hormone Replacement Therapy doesn’t deliver an advantageous effect on repressing the relative incidence or severity of Alzheimer’s disease.

Prevention is the Soundest Choice

Right now, while there’s still no Alzheimer’s disease remedy, there are more and more optimistic research reports being executed on Alzheimer’s disease prevention and risk decrease. Especially for those with a household history or additional risk elements for the disease, it’s essential to remain physically active, mentally aware, and socially engaged. Additionally, research is demonstrating that the life-style factors normally referenced as precluding heart disease, such as decrease in fat consumption and total cholesterol, could likewise assist in preventing Alzheimer’s disease. Until an Alzheimer’s remedy is discovered, prevention and overall health upkeep remain the soundest steps to take for most people.

67.7% of assisted living residents have dementia and 26.3% have an active non-cognitive psychiatric disorder. Screening has been found to be helpful in assisted living facilities and nursing homes.
Research shows that in nursing homes with treatment:
• 51% of participants with dementia and depression did improve their quality of life.
• 58% of those with depression alone, receiving counseling and medication recovered six months later and had a better quality of life.
• Only 25% of those receiving medication alone improved, but did not have a significantly better quality of life.
• Patients need to be seen 1-4 times per month in order to monitor-the constant fluctuation of behavioral and psychiatric symptoms and medical problems.
• Post stoke depression usually resolves in 6 months but can last two years.
In conclusion, patients who received psychotherapy (counseling) did 100% better than those that received medication alone. They also had a significant decrease in behavioral problems sooner and a better quality of life for longer.
Without psychotherapy, individuals with depression or dementia or both:
20% continued to-exhibit behavioral symptoms.
• 40% exhibited physically and/or verbally aggressive behavior
Because of these residents at nursing homes and assisted living facilities:
• Need to be routinely screened for depression
• All patients with behavioral problems need to be evaluated by a team of psychiatrist and mental health professionals.
• Most patients with many medical illnesses are not depressed.
• Staff needs to realize that many demented people will not spontaneously engage in activities because of depression or Alzheimer’s.
• Residents with dementia are taking several medications for problems such as insomnia or anxiety, the resident’s physician needs to review and possibly reduce the number of medications.
In conclusion, early evaluation and accurate comprehensive diagnosis is necessary. Medications alone are not enough. A comprehensive plan of 6-24 months with counseling is necessary to maximize results, prevent relapse and improve lie quality of life.